Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | Hu19-CD828Z T cells |
Synonyms | |
Therapy Description |
HuCD19 anti-CD19 CAR-T cells are T lymphocytes engineered to express a chimeric antigen receptor (CAR) targeting CD19, and containing CD8 hinge and transmembrane domains and CD28 costimulatory domains, which may induce antitumor activity (PMID: 31959992). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
Hu19-CD828Z T cells | HuCD19 anti-CD19 CAR-T cells | CD19 Immune Cell Therapy 62 | Hu19-CD828Z T cells are T-lymphocytes engineered to express a chimeric antigen receptor (CAR) that targets CD19, and contains CD8alpha hinge and transmembrane domains, a CD28 costimulatory domain, and a CD3 activation domain, which may induce antitumor activity (PMID: 31959992). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|